Wei Liu
Impact in
- Infectious Diseases top 0.05%
- Viral Infections and Vectors
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Viral Infections and Outbreaks Research
- Parasitology top 0.2%
- Vector-borne infectious diseases
Papers in
-
- Viral Infections and Vectors 103
- Viral gastroenteritis research and epidemiology 36
- SARS-CoV-2 and COVID-19 Research 33
- Antifungal resistance and susceptibility 30
- Viral Infections and Outbreaks Research 29
- Co-authors
- Wu‐Chun Cao (69 shared papers)Kui Liu (4 shared papers)Xiao‐Ai Zhang (92 shared papers)Huiguo Liu (5 shared papers)Yan Deng (3 shared papers)Hao Li (58 shared papers)Qing‐Bin Lu (67 shared papers)Ning Cui (44 shared papers)
- Journals
- Scientific Reports (20 papers)PLoS ONE (17 papers)Frontiers in Microbiology (16 papers)Emerging infectious diseases (15 papers)Journal of Medical Virology (13 papers)
- Partner nations
- ChinaUnited StatesBelarus
In The Last Decade
Wei Liu
1.1k papers receiving 25.1k citations
Wei Liu's Hit Papers
Peers
Comparison fields: 5 of 219
- Infectious Diseases 8.6k
- Parasitology 1.5k
- Virology 621
- Modeling and Simulation 573
- Neurology 1.7k
Countries citing papers authored by Wei Liu
This map shows the geographic impact of Wei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Liu more than expected).
Fields of papers citing papers by Wei Liu
This network shows the impact of papers produced by Wei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Liu. The network helps show where Wei Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.1k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province Hit paper breakdown → | 2020 | 1060 |
| 2 | Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease Hit paper breakdown → | 2020 | 769 |
| 3 | [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia]. Hit paper breakdown → | 2020 | 538 |
| 4 | Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study Hit paper breakdown → | 2020 | 505 |
| 5 | 2011 | 355 | |
| 6 | Nanozyme-strip for rapid local diagnosis of Ebola Hit paper breakdown → | 2015 | 346 |
| 7 | 2020 | 299 | |
| 8 | National and subnational trends in cancer burden in China, 2005–20: an analysis of national mortality surveillance data Hit paper breakdown → | 2023 | 290 |
| 9 | 2000 | 264 | |
| 10 | 2018 | 246 | |
| 11 | 2018 | 245 | |
| 12 | Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells. | 1997 | 240 |
| 13 | Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension Hit paper breakdown → | 2020 | 239 |
| 14 | 2015 | 234 | |
| 15 | 2006 | 203 | |
| 16 | 2014 | 174 | |
| 17 | Mapping ticks and tick-borne pathogens in China Hit paper breakdown → | 2021 | 173 |
| 18 | 2013 | 169 | |
| 19 | 2014 | 149 | |
| 20 | 2020 | 146 |
About Wei Liu
Wei Liu is a scholar working on Infectious Diseases, Molecular Biology, Epidemiology, Genetics and Pulmonary and Respiratory Medicine, having authored 1.1k papers that have together received 25.7k indexed citations. Recurring topics across this work include Viral Infections and Vectors (103 papers), Vector-borne infectious diseases (38 papers), Viral gastroenteritis research and epidemiology (36 papers), Mosquito-borne diseases and control (35 papers), SARS-CoV-2 and COVID-19 Research (33 papers), Antifungal resistance and susceptibility (30 papers), Viral Infections and Outbreaks Research (29 papers) and Viral Infections and Immunology Research (28 papers). The work is most often cited by research in Infectious Diseases (8.6k citations), Parasitology (1.5k citations), Virology (621 citations), Modeling and Simulation (573 citations) and Neurology (1.7k citations). Wei Liu has collaborated with scholars based in China, United States and Belarus. Frequent co-authors include Wu‐Chun Cao, Kui Liu, Xiao‐Ai Zhang, Huiguo Liu, Yan Deng, Hao Li, Qing‐Bin Lu, Ning Cui, Li‐Qun Fang and Ling Zhou. Their work appears in journals such as Scientific Reports, PLoS ONE, Frontiers in Microbiology, Emerging infectious diseases and Journal of Medical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.